Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1990; Volume 38,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adams, M E

    1. You have access
      Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;
  2. Adham, N

    1. You have access
      [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  3. Anderson, W R

    1. You have access
      Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;
  4. Ardies, C M

    1. You have access
      Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;
  5. Arnaudeau, S

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

B

  1. Bindokas, V P

    1. You have access
      Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;
  2. Branchek, T

    1. You have access
      [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
  3. Branchek, T A

    1. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

C

  1. Candell, L M

    1. You have access
      Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;
  2. Caron, M G

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;
  3. Clark, M A

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
  4. Collins, S

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;
  5. Costa, E

    1. You have access
      Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;
  6. Cribb, A E

    1. You have access
      Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;

D

  1. Dacquet, C

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  2. Dolphin, A C

    1. You have access
      Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;

E

  1. Egan, R W

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
  2. Ehlert, F J

    1. You have access
      Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

F

  1. Fredholm, B B

    1. You have access
      Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;

G

  1. Gerwins, P

    1. You have access
      Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;
  2. Grayson, D R

    1. You have access
      Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;
  3. Guenthner, T M

    1. You have access
      Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;

H

  1. Hartig, P R

    1. You have access
      [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  2. Hashimoto, K

    1. You have access
      Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;
  3. Higuchi, H

    1. You have access
      Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;
  4. Hoffman, B J

    1. You have access
      4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;

I

  1. Iwasa, A

    1. You have access
      Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;

J

  1. Jmari, K

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  2. Johnson, K M

    1. You have access
      Competitive inhibition of magnesium-induced [3H]N-(1-[thienyl] cyclohexyl)piperidine binding by arcaine: evidence for a shared spermidine-magnesium binding site.
      A I Sacaan and K M Johnson
      Molecular Pharmacology November 1990, 38 (5) 705-710;
  3. Jordan, V C

    1. You have access
      Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;

K

  1. Kamataki, T

    1. You have access
      Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;
  2. Kao, H T

    1. You have access
      [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
  3. Kitada, M

    1. You have access
      Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;
  4. Komori, M

    1. You have access
      Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

L

  1. Langan-Fahey, S M

    1. You have access
      Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;
  2. Lefkowitz, R J

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;
  3. Leonhardt, S

    1. You have access
      4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;
  4. Lichtblau, H

    1. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  5. Lomasney, J W

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;
  6. Lorenz, W

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

M

  1. Macchi, M

    1. You have access
      [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  2. Mante, S

    1. You have access
      Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
      S Mante and K P Minneman
      Molecular Pharmacology November 1990, 38 (5) 652-659;
  3. Martin, C

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  4. McCague, R

    1. You have access
      Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;
  5. Mehta, A K

    1. You have access
      gamma-Aminobutyric acidA receptor desensitization in mice spinal cord cultured neurons: lack of involvement of protein kinases A and C.
      M K Ticku and A K Mehta
      Molecular Pharmacology November 1990, 38 (5) 719-724;
  6. Miki, N

    1. You have access
      Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;
  7. Miller, M

    1. You have access
      Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;
  8. Minneman, K P

    1. You have access
      Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
      S Mante and K P Minneman
      Molecular Pharmacology November 1990, 38 (5) 652-659;
  9. Mironneau, C

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  10. Mironneau, J

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  11. Murphy, C S

    1. You have access
      Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;
  12. Musílková, J

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

N

  1. Nedoma, J

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;
  2. Nordstedt, C

    1. You have access
      Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;

P

  1. Park, S S

    1. You have access
      Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;
  2. Proska, J

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;
  3. Prozialeck, W C

    1. You have access
      Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;

R

  1. Rakotoarisoa, L

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  2. Regan, J W

    1. You have access
      Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

S

  1. Sacaan, A I

    1. You have access
      Competitive inhibition of magnesium-induced [3H]N-(1-[thienyl] cyclohexyl)piperidine binding by arcaine: evidence for a shared spermidine-magnesium binding site.
      A I Sacaan and K M Johnson
      Molecular Pharmacology November 1990, 38 (5) 705-710;
  2. Sayet, I

    1. You have access
      Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;
  3. Scott, R H

    1. You have access
      Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;
  4. Shelkovnikov, S

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;
  5. Shih, N Y

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
  6. Siegel, M I

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
  7. Spielberg, S P

    1. You have access
      Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;
  8. Suzuki, E

    1. You have access
      Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;
  9. Szekely, A M

    1. You have access
      Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;

T

  1. Tamura, K

    1. You have access
      Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;
  2. Teitler, M

    1. You have access
      4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;
  3. Tesoro, A

    1. You have access
      Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;
  4. Ticku, M K

    1. You have access
      gamma-Aminobutyric acidA receptor desensitization in mice spinal cord cultured neurons: lack of involvement of protein kinases A and C.
      M K Ticku and A K Mehta
      Molecular Pharmacology November 1990, 38 (5) 719-724;
  5. Tran, L L

    1. You have access
      Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;
  6. Trudell, J R

    1. You have access
      Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;
  7. Tsujimoto, G

    1. You have access
      Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;
  8. Tucek, S

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

U

  1. Uchida, T

    1. You have access
      Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

V

  1. Vorlícek, J

    1. You have access
      Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

W

  1. Weinshank, R L

    1. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  2. Weisberg, E L

    1. You have access
      4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;
  3. Weiss, B

    1. You have access
      Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;
  4. West, R E

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
  5. Wheeler, C W

    1. You have access
      Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;

Y

  1. Yoshida, H

    1. You have access
      Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;
  2. Yun, S H

    1. You have access
      Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

Z

  1. Zgombick, J M

    1. You have access
      Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;
  2. Zhang, S P

    1. You have access
      Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;
  3. Zweig, A

    1. You have access
      Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 38, Issue 5
1 Nov 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics